Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1958 of 1958 entries
View as:

A Study of LY8888AX in Participants Using a Connected Insulin Management Platform

Phase: N/A Priority: Normal
NCT ID: NCT05893797 Org: User:
Start: 10/05/23 End: 09/16/24 Due: 09/16/25

A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01115803 Org: User:
Start: 03/31/10 End: 06/30/11 Due: 06/30/12

A Study of LY3437943 in Participants With Impaired and Normal Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT05916560 Org: User:
Start: 07/13/23 End: 03/02/25 Due: 03/02/26

Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05169567 Org: User:
Start: 03/11/22 End: 02/28/26 Due: 02/28/27

A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight

Phase: N/A Priority: Normal
NCT ID: NCT06230523 Org: User:
Start: 02/05/24 End: 09/30/25 Due: 09/30/26

A Study of LY3009104 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01536951 Org: User:
Start: 02/29/12 End: 05/31/13 Due: 05/31/14

An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.

Phase: N/A Priority: Normal
NCT ID: NCT00510211 Org: User:
Start: 04/30/07 End: 05/31/09 Due: 05/31/10

A Study of LY3841136 in Overweight and Obese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06345066 Org: User:
Start: 04/03/24 End: 10/31/25 Due: 10/31/26